| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,899,000 | 2,089,000 | 2,310,000 | 1,930,000 | | Cost of Revenue | 274,000 | 322,000 | 290,000 | 278,000 | | | Gross Profit | 1,625,000 | 1,767,000 | 2,020,000 | 1,652,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 946,000 | 1,056,000 | 967,000 | 861,000 | | Non Recurring |
-
| 965,000 |
-
|
-
| | Others | 813,000 | 2,398,000 | 985,000 | 719,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (134,000) | (2,652,000) | 68,000 | 72,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (134,000) | (2,652,000) | 68,000 | 72,000 | | Interest Expense | 128,000 | 191,000 | 196,000 | 190,000 | | Income Before Tax | (262,000) | (2,843,000) | (128,000) | (118,000) | | Income Tax Expense | (312,000) | (701,000) | (73,000) | 84,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 50,000 | (2,142,000) | (55,000) | (202,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,000 | (2,142,000) | (55,000) | (202,000) | | Preferred Stock And Other Adjustments | (76,000) | (41,000) | (26,000) |
-
| | | Net Income Applicable To Common Shares | ($26,000) | ($2,183,000) | ($81,000) | ($202,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
